Publicacions (148) Publicacions de JESÚS MORENO SIERRA

2024

  1. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor

    Therapeutic Advances in Urology, Vol. 16

  2. Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer: A Systematic Review

    European Urology Open Science, Vol. 63, pp. 126-135

  3. Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters

    European urology oncology, Vol. 7, Núm. 2, pp. 231-240

2023

  1. A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells

    Cellular and Molecular Immunology, Vol. 20, Núm. 12, pp. 1499-1512

  2. Androgen deprivation therapy in localized prostate cancer. Current status and future trends

    Actas Urologicas Espanolas, Vol. 47, Núm. 7, pp. 398-407

  3. Cystic Renal Lesions: A Systematic Review of Diagnosis and Treatment

    Kidney Cancer, Vol. 7, Núm. 1, pp. 95-114

  4. Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer: Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs

    Journal of Personalized Medicine, Vol. 13, Núm. 12

  5. Optimising the management of bone related effets of androgen deprivation therapy in prostate cancer in the non-castration resistant scenario

    Actas Urologicas Espanolas

  6. Pyeloenteric Fistula

    Urinary Fistula (Springer Singapore), pp. 33-42

  7. Pyeloureteral Anastomosis as a Reconstructive Technique for Post-Renal Transplant Ureteral Stenosis

    Urology Research and Practice, Vol. 49, Núm. 6, pp. 406-412

  8. The Use of Radiomic Tools in Renal Mass Characterization

    Diagnostics, Vol. 13, Núm. 17

2022

  1. Impact of lifestyle in prostate cancer patients. What should we do?

    International Braz J Urol, Vol. 48, Núm. 2, pp. 244-262

  2. Impacto de la COVID-19 sobre la reestructuración y organización en urología

    Archivos espanoles de urologia, Vol. 75, Núm. 3, pp. 215-218

  3. Improving oncological outcomes after robotassisted radical prostatectomy: what novel tools do we have?

    Mini-invasive Surgery, Vol. 6

  4. New therapies for neurovascular bundles regeneration after radical prostatectomy: A narrative review on clinical studies

    Frontiers in Urology, Vol. 2

  5. Urodinámica de la RAO en el síndrome De Guillain-Barré post-infección por coronavirus Sars-Cov-2. Revisión bibliográfica

    Archivos espanoles de urologia, Vol. 75, Núm. 1, pp. 7-18

2021

  1. Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications

    Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 840-845

  2. Calcificaciones anormales en tumor renal de células cromófobas: descripción de un caso clínico y revisión de la literatura

    Archivos espanoles de urologia, Vol. 74, Núm. 3, pp. 355-359

  3. Prevalencia y factores de riesgo de síntomas del tracto urinario inferior post sacrocolpopexia robótica

    Archivos Espanoles de Urologia, Vol. 74, Núm. 5, pp. 494-502

  4. The Uro-oncology Patient and Vaccination Against SARS-CoV-2

    European Urology Open Science